Section 174A has fundamentally changed how businesses treat R&D costs—introducing capitalization requirements that directly impact cash flow, tax liability, and financial planning. This guide breaks down what you need to know and how to respond strategically.
What you’ll learn
Section 174A has reshaped the R&D tax landscape, requiring companies to capitalize and amortize research expenditures rather than deduct them immediately—creating new financial and compliance challenges.
In this guide, you’ll discover:
What Section 174A is and why it matters
How capitalization affects your tax position and cash flow
The relationship between Section 174A and the R&D Tax Credit
Common pitfalls and compliance risks
Strategic approaches to mitigate impact
Why Section 174A matters
For decades, businesses could deduct R&D expenses immediately. Section 174A changes that—requiring amortization over multiple years, even for unsuccessful projects.
This shift introduces:
- Increased taxable income in the short term
- Reduced cash flow and delayed benefits
- Greater complexity in tax reporting and documentation
Understanding these implications is critical to maintaining financial efficiency and compliance.
Who should read this guide?
This guide is designed for:
- CFOs and Finance Leaders
- Tax Directors and CPAs
- R&D and Engineering Leaders
- Business Owners investing in innovation
If your organization incurs development costs, builds new products, or improves processes, Section 174A likely affects you.
Why work with Ayming
At Ayming, we help businesses turn complex tax policy into actionable strategy. Our experts combine technical, financial, and tax expertise to ensure you stay compliant while maximizing available incentives.
- Proven track record in R&D tax consulting
- Deep expertise in evolving legislation like Section 174A
- End-to-end support—from analysis to documentation
- Global perspective with local execution
We don’t just interpret policy, we help you act on it.
